| 000 | 01024 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513235011.0 | ||
| 264 | 0 | _c20010802 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1060-0280 | ||
| 024 | 7 |
_a10.1345/aph.10076b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSherman, J J | |
| 245 | 0 | 0 |
_aComment: other factors should be considered in a possible warfarin and sulfasalazine interaction. _h[electronic resource] |
| 260 |
_bThe Annals of pharmacotherapy _cApr 2001 |
||
| 300 |
_a506 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 35 _gno. 4 _gp. 506 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1345/aph.10076b _zAvailable from publisher's website |
| 999 |
_c11237315 _d11237315 |
||